WallStreetZenWallStreetZen

NASDAQ: ABVX
Abivax Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ABVX

Based on 11 analysts offering 12 month price targets for Abivax Sa

Min Forecast
$70.00-39.1%
Avg Forecast
$123.36+7.33%
Max Forecast
$176.00+53.12%

Should I buy or sell ABVX stock?

Based on 11 analysts offering ratings for Abivax Sa.

Strong Buy
Strong Buy
7 analysts 63.64%
Buy
4 analysts 36.36%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ABVX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ABVX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ABVX stock forecasts and price targets.

ABVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-16
lockedlocked$00.00+00.00%2025-11-24
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-10-13
lockedlocked$00.00+00.00%2025-10-10Find Out Why
BTIG
Top 4%
97
Strong BuyMaintains$120.00+4.40%2025-10-07Find out why
JMP Securities
Top 50%
51
BuyMaintains$114.00-0.82%2025-09-25
Morgan Stanley
Bottom 10%
10
Strong BuyMaintains$101.00-12.13%2025-09-12
Piper Sandler
Top 7%
94
Strong BuyMaintains$112.00-2.56%2025-07-29Find out why
Piper Sandler
Bottom 13%
13
Strong BuyMaintains$70.00-39.10%2025-07-23

1 of 2

Forecast return on equity

Is ABVX forecast to generate an efficient return?

Company
N/A
Industry
250.21%
Market
226.77%

Forecast return on assets

Is ABVX forecast to generate an efficient return on assets?

Company
N/A
Industry
89.93%

ABVX earnings per share forecast

What is ABVX's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$2.75
Avg 2 year Forecast
-$0.64
Avg 3 year Forecast
-$2.84

ABVX revenue forecast

What is ABVX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$11.5M
Avg 2 year Forecast
$8.1M
Avg 3 year Forecast
$249.5M

ABVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABVX$114.94$123.36+7.33%Strong Buy
CORT$83.76$125.25+49.53%Strong Buy
HALO$67.35$77.13+14.51%Buy
AXSM$152.65$179.60+17.65%Strong Buy
TECH$58.27$70.33+20.70%Strong Buy
View Top Biotech Stocks

Abivax Sa Stock Forecast FAQ

Is Abivax Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: ABVX) stock is to Strong Buy ABVX stock.

Out of 11 analysts, 7 (63.64%) are recommending ABVX as a Strong Buy, 4 (36.36%) are recommending ABVX as a Buy, 0 (0%) are recommending ABVX as a Hold, 0 (0%) are recommending ABVX as a Sell, and 0 (0%) are recommending ABVX as a Strong Sell.

If you're new to stock investing, here's how to buy Abivax Sa stock.

What is ABVX's earnings growth forecast for 2025-2027?

(NASDAQ: ABVX) Abivax Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.4%.

Abivax Sa's earnings in 2025 is N/A.On average, 9 Wall Street analysts forecast ABVX's earnings for 2025 to be -$200,567,642, with the lowest ABVX earnings forecast at -$247,339,526, and the highest ABVX earnings forecast at -$96,505,306. On average, 8 Wall Street analysts forecast ABVX's earnings for 2026 to be -$46,874,006, with the lowest ABVX earnings forecast at -$244,480,109, and the highest ABVX earnings forecast at $768,978,790.

In 2027, ABVX is forecast to generate -$206,840,851 in earnings, with the lowest earnings forecast at -$250,198,942 and the highest earnings forecast at -$147,821,620.

What is ABVX's revenue growth forecast for 2025-2027?

(NASDAQ: ABVX) Abivax Sa's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 99.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.47%.

Abivax Sa's revenue in 2025 is N/A.On average, 8 Wall Street analysts forecast ABVX's revenue for 2025 to be $840,755,979, with the lowest ABVX revenue forecast at $285,941,648, and the highest ABVX revenue forecast at $2,297,745,387. On average, 8 Wall Street analysts forecast ABVX's revenue for 2026 to be $593,985,419, with the lowest ABVX revenue forecast at $285,941,648, and the highest ABVX revenue forecast at $949,734,760.

In 2027, ABVX is forecast to generate $18,197,414,022 in revenue, with the lowest revenue forecast at $5,776,021,293 and the highest revenue forecast at $45,993,568,218.

What is ABVX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ABVX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 89.93%.

What is ABVX's Price Target?

According to 11 Wall Street analysts that have issued a 1 year ABVX price target, the average ABVX price target is $123.36, with the highest ABVX stock price forecast at $176.00 and the lowest ABVX stock price forecast at $70.00.

On average, Wall Street analysts predict that Abivax Sa's share price could reach $123.36 by Dec 16, 2026. The average Abivax Sa stock price prediction forecasts a potential upside of 7.33% from the current ABVX share price of $114.94.

What is ABVX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ABVX) Abivax Sa's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that ABVX's EPS will be -$2.75 for 2025, with the lowest EPS forecast at -$3.39, and the highest EPS forecast at -$1.32. On average, analysts forecast that ABVX's EPS will be -$0.64 for 2026, with the lowest EPS forecast at -$3.35, and the highest EPS forecast at $10.54. In 2027, ABVX's EPS is forecast to hit -$2.84 (min: -$3.43, max: -$2.03).

What is ABVX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ABVX) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.